Bioasis Technologies Inc.

BIOAF · OTC
Analyze with AI
11/30/2022
8/31/2022
5/31/2022
2/28/2022
Assets
Cash & Equivalents$157$568$765$1,731
Short-Term Investments$0$0$0$0
Receivables$14$18$0$98
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$384$908$1,143$2,107
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$1,379$1,414$146$159
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$1,380$1,414$146$159
Other Assets$0$0$0$0
Total Assets$1,763$2,323$1,289$2,266
Liabilities
Payables$1,859$1,540$1,204$1,489
Short-Term Debt$1,500$1,500$1,500$1,500
Tax Payable$0$0$0$0
Deferred Revenue$245$394$321$0
Other Curr. Liab.$0$0$0$0
Total Curr. Liab.$3,604$3,434$3,025$2,989
LT Debt$714$504$273$402
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$143$86$136$792
Total NC Liab.$857$589$409$1,194
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$4,460$4,023$3,434$4,183
Equity
Pref Stock$0$0$0$0
Common Stock$28,754$28,754$27,454$27,454
Retained Earnings-$42,963-$41,977-$40,887-$40,654
AOCI$155$170$186$185
Other Equity$0$0$0$0
Total Equity-$2,697-$1,701-$2,145-$1,917
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,763$2,323$1,289$2,266
Net Debt$2,057$1,435$1,008$171